Iron Med RX review

Iron Med RX currently lists sermorelin injection from $149 per month and NAD⁺ injection at 500 mg from $140 or 1,000 mg from $220, plus nasal and oral NAD⁺ routes. Its examined public treatments catalog does not list the BPC-157 or CJC-1295/ipamorelin offers previously described. That is a catalog change, not proof those therapies permanently ended. The starting figures are not tied to a selected monthly, three-month or six-month plan, so confirm the first debit, supply and treating group before buying.

Iron Med RX is an online treatment platform with a published Newark, Delaware address and support contact details. Its current public catalog lists sermorelin in injection and oral forms, NAD⁺ as 500 mg and 1,000 mg injections plus nasal and oral options, and glutathione injection. It also describes weight-care products. The examined catalog does not list the BPC-157 or CJC-1295/ipamorelin offers shown in older review copy. Public About and terms describe partner clinicians and pharmacy fulfillment, without establishing that prescribers are employed in-house or naming the pharmacy assigned to a selected order.

The service describes an online intake with state selection, professional review and a prescription decision; some cases may require a synchronous visit. If approved, a partner pharmacy fulfills the order, and the NAD⁺ page advertises free discreet shipping. The public material does not establish a named prescribing group, selected pharmacy or product-specific state list. Terms say cancellation or refund can be requested before approval, while amounts may be limited or unavailable after approval, pharmacy processing or shipment; a declined treatment may still involve fees for services rendered. Lab inclusion for a selected peptide or NAD⁺ plan is not established. Ask who will prescribe, what monitoring is required and what the selected plan costs before authorizing payment.

Current public product pages show starting figures of $149 per month for sermorelin injection, $140 for NAD⁺ 500 mg injection and $220 for NAD⁺ 1,000 mg injection; the catalog also shows NAD⁺ nasal 900 mg from $149. Product pages mention monthly, three-month and six-month options without connecting each starting figure to a selected plan, full first debit, dose or supply duration. BPC-157 and CJC-1295/ipamorelin are absent from the examined public treatments catalog; those products have no current public comparison price here. Terms allow refill subscriptions under checkout/account rules and require cancellation before renewal. Confirm the selected route, total charge, renewal date, pharmacy and refund position before paying.

Compounded products are not FDA-approved finished drugs; a prescription requires a licensed professional to find treatment appropriate. The site describes licensed partner pharmacies without identifying the dispenser assigned to a specific product. Among currently visible options, sermorelin acts on the growth-hormone axis, a genuine mechanism with thin long-term human outcome data and no controlled trial proving anti-aging or body-composition benefit. Injected and intranasal NAD⁺ have no controlled human outcome trials for the advertised longevity benefits; oral NR and NMN studies show a raised blood NAD⁺ level rather than a demonstrated clinical outcome. The catalog also lists an oral NAD⁺ form, which should not be equated with studied precursor supplements. Product route, dose, clinical monitoring and pharmacy should be confirmed for the selected prescription. Individual results vary.